Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies
Induction of broadly neutralising antibodies (bnAbs) capable of inhibiting infection with diverse variants of human immunodeficiency virus type 1 (HIV-1) is a key, as-yet-unachieved goal of prophylactic HIV-1 vaccine strategies. However some HIV-infected individuals develop bnAbs after ~2-4 years of...
मुख्य लेखकों: | Borrow, P, Moody, M |
---|---|
स्वरूप: | Journal article |
प्रकाशित: |
Wiley
2017
|
समान संसाधन
-
Immune perturbations in HIV-1–infected individuals who make broadly neutralizing antibodies
द्वारा: Moody, M, और अन्य
प्रकाशित: (2016) -
Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
द्वारा: Elise Landais, और अन्य
प्रकाशित: (2018-09-01) -
Immunologic Basis for Long HCDR3s in Broadly Neutralizing Antibodies against HIV-1
द्वारा: Lei eYu, और अन्य
प्रकाशित: (2014-06-01) -
Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
द्वारा: Haynes, BF, और अन्य
प्रकाशित: (2022) -
Broadly Neutralizing Antibody Responses in a Subset of HIV-1-Infected Individuals in Chennai, India
द्वारा: Syed Iqbal Hussain PhD, और अन्य
प्रकाशित: (2017-03-01)